K. Detjen et al., TRANSFECTED CHOLECYSTOKININ RECEPTORS MEDIATE GROWTH-INHIBITORY EFFECTS ON HUMAN PANCREATIC-CANCER CELL-LINES, Gastroenterology, 112(3), 1997, pp. 952-959
Background & Aims: Cholecystokinin (CCK) acting via CCK, receptors and
gastrin acting via CCK, receptors exert trophic effects on a variety
of nontransformed tissues. However, their role as hormonal regulators
of pancreatic cancer is controversial. The aim of this study was to de
termine the effects of activation of CCK, and CCK, receptors on the gr
owth of human pancreatic cancer cells in vitro. Methods: Two human pan
creatic cell lines MiaPaca-2 and Panc-1 were transfected stably with b
oth CCK receptor subtypes. Effects of CCK on various growth parameters
including DNA synthesis, nuclear labeling, and colony formation were
evaluated. Results: Cells expressing either receptor subtype, but not
untransfected cells, bound ligand and mobilized Ca2+ in response to CC
K. CCK treatment caused a sustained pronounced inhibition of anchorage
-independent growth. Similarly, CCK treatment inhibited anchorage-depe
ndent growth. Receptor activation caused a concentration and time-depe
ndent reduction in [H-3]thymidine incorporation and nuclear labeling i
n cells cultured anchored to a plastic substrate. However, these effec
ts on anchorage-dependent growth were transient, suggesting cellular d
esensitization. Conclusions: These data indicate that both CCK recepto
r subtypes can mediate growth inhibitory responses in pancreatic cance
r cell lines and raise the possibility that CCK exerts a predominant g
rowth inhibitory action on human pancreatic cancer cells.